Parkinson's Disease (PD) Drugs Market - Global Outlook and Forecast 2022-2028

Parkinson's Disease (PD) Drugs Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Parkinson's Disease (PD) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parkinson's Disease (PD) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Parkinson's Disease (PD) Drugs Overall Market Size
2.1 Global Parkinson's Disease (PD) Drugs Market Size: 2021 VS 2028
2.2 Global Parkinson's Disease (PD) Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Parkinson's Disease (PD) Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Parkinson's Disease (PD) Drugs Players in Global Market
3.2 Top Global Parkinson's Disease (PD) Drugs Companies Ranked by Revenue
3.3 Global Parkinson's Disease (PD) Drugs Revenue by Companies
3.4 Global Parkinson's Disease (PD) Drugs Sales by Companies
3.5 Global Parkinson's Disease (PD) Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Parkinson's Disease (PD) Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Parkinson's Disease (PD) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Parkinson's Disease (PD) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Parkinson's Disease (PD) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Parkinson's Disease (PD) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Parkinson's Disease (PD) Drugs Market Size Markets, 2021 & 2028
4.1.2 Dopamine Agonist
4.1.3 Monoamine Oxidase Inhibitors
4.1.4 Acetylcholinesterase Inhibitors
4.1.5 Glutamate Inhibitors
4.2 By Type - Global Parkinson's Disease (PD) Drugs Revenue & Forecasts
4.2.1 By Type - Global Parkinson's Disease (PD) Drugs Revenue, 2017-2022
4.2.2 By Type - Global Parkinson's Disease (PD) Drugs Revenue, 2023-2028
4.2.3 By Type - Global Parkinson's Disease (PD) Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Parkinson's Disease (PD) Drugs Sales & Forecasts
4.3.1 By Type - Global Parkinson's Disease (PD) Drugs Sales, 2017-2022
4.3.2 By Type - Global Parkinson's Disease (PD) Drugs Sales, 2023-2028
4.3.3 By Type - Global Parkinson's Disease (PD) Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Parkinson's Disease (PD) Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Parkinson's Disease (PD) Drugs Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Family
5.2 By Application - Global Parkinson's Disease (PD) Drugs Revenue & Forecasts
5.2.1 By Application - Global Parkinson's Disease (PD) Drugs Revenue, 2017-2022
5.2.2 By Application - Global Parkinson's Disease (PD) Drugs Revenue, 2023-2028
5.2.3 By Application - Global Parkinson's Disease (PD) Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Parkinson's Disease (PD) Drugs Sales & Forecasts
5.3.1 By Application - Global Parkinson's Disease (PD) Drugs Sales, 2017-2022
5.3.2 By Application - Global Parkinson's Disease (PD) Drugs Sales, 2023-2028
5.3.3 By Application - Global Parkinson's Disease (PD) Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Parkinson's Disease (PD) Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Parkinson's Disease (PD) Drugs Market Size, 2021 & 2028
6.2 By Region - Global Parkinson's Disease (PD) Drugs Revenue & Forecasts
6.2.1 By Region - Global Parkinson's Disease (PD) Drugs Revenue, 2017-2022
6.2.2 By Region - Global Parkinson's Disease (PD) Drugs Revenue, 2023-2028
6.2.3 By Region - Global Parkinson's Disease (PD) Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Parkinson's Disease (PD) Drugs Sales & Forecasts
6.3.1 By Region - Global Parkinson's Disease (PD) Drugs Sales, 2017-2022
6.3.2 By Region - Global Parkinson's Disease (PD) Drugs Sales, 2023-2028
6.3.3 By Region - Global Parkinson's Disease (PD) Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Parkinson's Disease (PD) Drugs Revenue, 2017-2028
6.4.2 By Country - North America Parkinson's Disease (PD) Drugs Sales, 2017-2028
6.4.3 US Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.4.4 Canada Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.4.5 Mexico Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Parkinson's Disease (PD) Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Parkinson's Disease (PD) Drugs Sales, 2017-2028
6.5.3 Germany Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.5.4 France Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.5.5 U.K. Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.5.6 Italy Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.5.7 Russia Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.5.9 Benelux Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Parkinson's Disease (PD) Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Parkinson's Disease (PD) Drugs Sales, 2017-2028
6.6.3 China Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.6.4 Japan Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.6.5 South Korea Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.6.7 India Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Parkinson's Disease (PD) Drugs Revenue, 2017-2028
6.7.2 By Country - South America Parkinson's Disease (PD) Drugs Sales, 2017-2028
6.7.3 Brazil Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.7.4 Argentina Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Sales, 2017-2028
6.8.3 Turkey Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.8.4 Israel Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Parkinson's Disease (PD) Drugs Market Size, 2017-2028
6.8.6 UAE Parkinson's Disease (PD) Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Corporate Summary
7.1.2 Boehringer Ingelheim Business Overview
7.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Major Product Offerings
7.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Boehringer Ingelheim Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.2.5 GlaxoSmithKline Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Parkinson's Disease (PD) Drugs Major Product Offerings
7.3.4 Novartis Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Novartis Key News
7.4 Teva Pharmaceutical Industries
7.4.1 Teva Pharmaceutical Industries Corporate Summary
7.4.2 Teva Pharmaceutical Industries Business Overview
7.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Major Product Offerings
7.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Teva Pharmaceutical Industries Key News
7.5 AbbVie
7.5.1 AbbVie Corporate Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie Parkinson's Disease (PD) Drugs Major Product Offerings
7.5.4 AbbVie Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.5.5 AbbVie Key News
7.6 Abital Pharma
7.6.1 Abital Pharma Corporate Summary
7.6.2 Abital Pharma Business Overview
7.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Major Product Offerings
7.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Abital Pharma Key News
7.7 Addex Therapeutics
7.7.1 Addex Therapeutics Corporate Summary
7.7.2 Addex Therapeutics Business Overview
7.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Major Product Offerings
7.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Addex Therapeutics Key News
7.8 Biogen
7.8.1 Biogen Corporate Summary
7.8.2 Biogen Business Overview
7.8.3 Biogen Parkinson's Disease (PD) Drugs Major Product Offerings
7.8.4 Biogen Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Biogen Key News
7.9 Eisai
7.9.1 Eisai Corporate Summary
7.9.2 Eisai Business Overview
7.9.3 Eisai Parkinson's Disease (PD) Drugs Major Product Offerings
7.9.4 Eisai Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Eisai Key News
7.10 Eli Lilly
7.10.1 Eli Lilly Corporate Summary
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Major Product Offerings
7.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Eli Lilly Key News
7.11 F. Hoffmann-La Roche
7.11.1 F. Hoffmann-La Roche Corporate Summary
7.11.2 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Business Overview
7.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Major Product Offerings
7.11.4 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.11.5 F. Hoffmann-La Roche Key News
7.12 H. Lundbeck
7.12.1 H. Lundbeck Corporate Summary
7.12.2 H. Lundbeck Parkinson's Disease (PD) Drugs Business Overview
7.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Major Product Offerings
7.12.4 H. Lundbeck Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.12.5 H. Lundbeck Key News
7.13 Impax Laboratories
7.13.1 Impax Laboratories Corporate Summary
7.13.2 Impax Laboratories Parkinson's Disease (PD) Drugs Business Overview
7.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Major Product Offerings
7.13.4 Impax Laboratories Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Impax Laboratories Key News
7.14 Kyowa Hakko Kirin
7.14.1 Kyowa Hakko Kirin Corporate Summary
7.14.2 Kyowa Hakko Kirin Business Overview
7.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Major Product Offerings
7.14.4 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Kyowa Hakko Kirin Key News
7.15 Otsuka Pharmaceutical
7.15.1 Otsuka Pharmaceutical Corporate Summary
7.15.2 Otsuka Pharmaceutical Business Overview
7.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Major Product Offerings
7.15.4 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Otsuka Pharmaceutical Key News
7.16 Pfizer
7.16.1 Pfizer Corporate Summary
7.16.2 Pfizer Business Overview
7.16.3 Pfizer Parkinson's Disease (PD) Drugs Major Product Offerings
7.16.4 Pfizer Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Pfizer Key News
8 Global Parkinson's Disease (PD) Drugs Production Capacity, Analysis
8.1 Global Parkinson's Disease (PD) Drugs Production Capacity, 2017-2028
8.2 Parkinson's Disease (PD) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Parkinson's Disease (PD) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Parkinson's Disease (PD) Drugs Supply Chain Analysis
10.1 Parkinson's Disease (PD) Drugs Industry Value Chain
10.2 Parkinson's Disease (PD) Drugs Upstream Market
10.3 Parkinson's Disease (PD) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Parkinson's Disease (PD) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Parkinson's Disease (PD) Drugs in Global Market
Table 2. Top Parkinson's Disease (PD) Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Parkinson's Disease (PD) Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Parkinson's Disease (PD) Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Parkinson's Disease (PD) Drugs Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Parkinson's Disease (PD) Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Parkinson's Disease (PD) Drugs Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table 9. List of Global Tier 1 Parkinson's Disease (PD) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Parkinson's Disease (PD) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Parkinson's Disease (PD) Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Parkinson's Disease (PD) Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Parkinson's Disease (PD) Drugs Sales (K Pcs), 2017-2022
Table 15. By Type - Global Parkinson's Disease (PD) Drugs Sales (K Pcs), 2023-2028
Table 16. By Application - Global Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Parkinson's Disease (PD) Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Parkinson's Disease (PD) Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Parkinson's Disease (PD) Drugs Sales (K Pcs), 2017-2022
Table 20. By Application - Global Parkinson's Disease (PD) Drugs Sales (K Pcs), 2023-2028
Table 21. By Region - Global Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Parkinson's Disease (PD) Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Parkinson's Disease (PD) Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Parkinson's Disease (PD) Drugs Sales (K Pcs), 2017-2022
Table 25. By Region - Global Parkinson's Disease (PD) Drugs Sales (K Pcs), 2023-2028
Table 26. By Country - North America Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2023-2028
Table 46. Boehringer Ingelheim Corporate Summary
Table 47. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Offerings
Table 48. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. GlaxoSmithKline Corporate Summary
Table 50. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Offerings
Table 51. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Novartis Corporate Summary
Table 53. Novartis Parkinson's Disease (PD) Drugs Product Offerings
Table 54. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Teva Pharmaceutical Industries Corporate Summary
Table 56. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Offerings
Table 57. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. AbbVie Corporate Summary
Table 59. AbbVie Parkinson's Disease (PD) Drugs Product Offerings
Table 60. AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Abital Pharma Corporate Summary
Table 62. Abital Pharma Parkinson's Disease (PD) Drugs Product Offerings
Table 63. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Addex Therapeutics Corporate Summary
Table 65. Addex Therapeutics Parkinson's Disease (PD) Drugs Product Offerings
Table 66. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Biogen Corporate Summary
Table 68. Biogen Parkinson's Disease (PD) Drugs Product Offerings
Table 69. Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Eisai Corporate Summary
Table 71. Eisai Parkinson's Disease (PD) Drugs Product Offerings
Table 72. Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Eli Lilly Corporate Summary
Table 74. Eli Lilly Parkinson's Disease (PD) Drugs Product Offerings
Table 75. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. F. Hoffmann-La Roche Corporate Summary
Table 77. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Offerings
Table 78. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. H. Lundbeck Corporate Summary
Table 80. H. Lundbeck Parkinson's Disease (PD) Drugs Product Offerings
Table 81. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Impax Laboratories Corporate Summary
Table 83. Impax Laboratories Parkinson's Disease (PD) Drugs Product Offerings
Table 84. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Kyowa Hakko Kirin Corporate Summary
Table 86. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Offerings
Table 87. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. Otsuka Pharmaceutical Corporate Summary
Table 89. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Offerings
Table 90. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 91. Pfizer Corporate Summary
Table 92. Pfizer Parkinson's Disease (PD) Drugs Product Offerings
Table 93. Pfizer Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 94. Parkinson's Disease (PD) Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 95. Global Parkinson's Disease (PD) Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 96. Global Parkinson's Disease (PD) Drugs Production by Region, 2017-2022 (K Pcs)
Table 97. Global Parkinson's Disease (PD) Drugs Production by Region, 2023-2028 (K Pcs)
Table 98. Parkinson's Disease (PD) Drugs Market Opportunities & Trends in Global Market
Table 99. Parkinson's Disease (PD) Drugs Market Drivers in Global Market
Table 100. Parkinson's Disease (PD) Drugs Market Restraints in Global Market
Table 101. Parkinson's Disease (PD) Drugs Raw Materials
Table 102. Parkinson's Disease (PD) Drugs Raw Materials Suppliers in Global Market
Table 103. Typical Parkinson's Disease (PD) Drugs Downstream
Table 104. Parkinson's Disease (PD) Drugs Downstream Clients in Global Market
Table 105. Parkinson's Disease (PD) Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Parkinson's Disease (PD) Drugs Segment by Type
Figure 2. Parkinson's Disease (PD) Drugs Segment by Application
Figure 3. Global Parkinson's Disease (PD) Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Parkinson's Disease (PD) Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Parkinson's Disease (PD) Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Parkinson's Disease (PD) Drugs Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Parkinson's Disease (PD) Drugs Revenue in 2021
Figure 9. By Type - Global Parkinson's Disease (PD) Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Parkinson's Disease (PD) Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Parkinson's Disease (PD) Drugs Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Parkinson's Disease (PD) Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Parkinson's Disease (PD) Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Parkinson's Disease (PD) Drugs Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Parkinson's Disease (PD) Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Parkinson's Disease (PD) Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Parkinson's Disease (PD) Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Parkinson's Disease (PD) Drugs Sales Market Share, 2017-2028
Figure 19. US Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Parkinson's Disease (PD) Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Parkinson's Disease (PD) Drugs Sales Market Share, 2017-2028
Figure 24. Germany Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Parkinson's Disease (PD) Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Parkinson's Disease (PD) Drugs Sales Market Share, 2017-2028
Figure 33. China Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Parkinson's Disease (PD) Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Parkinson's Disease (PD) Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Parkinson's Disease (PD) Drugs Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Parkinson's Disease (PD) Drugs by Region, 2021 VS 2028
Figure 50. Parkinson's Disease (PD) Drugs Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs